Liyan R. Huang
State Key Laboratory Of Respiratory Disease & National Clinical Research Center For Respiratory Disease
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Proteomic profiling of early-stage non-small cell lung cancer identifies a high-performance protein signature associated with postoperative recurrence.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 21, 2025
Development and clinical validation of a dual ddPCR assay for detecting carbapenem-resistant Acinetobacter baumannii in bloodstream infections.
Journal: Frontiers in microbiology
Published: November 14, 2023
Advances in clinical studies of chronic cough
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: September 26, 2023
Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: June 15, 2022
Over-shedding of donor-derived cell-free DNA at immune-related regions into plasma of lung transplant recipient.
Journal: Clinical and translational medicine
Published: July 12, 2021
Rhophilin-2 Upregulates Glutamine Synthetase by Stabilizing c-Myc Protein and Confers Resistance to Glutamine Deprivation in Lung Cancer.
Journal: Frontiers in oncology
Published: June 15, 2020
Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
Journal: The Journal of infectious diseases
Published: March 07, 2020
Genetic alteration profile of EGFR-mutant resected IIB-IIIA stage NSCLC and correlation to clinical outcomes.
Journal: Translational lung cancer research
Published: February 04, 2020
Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance.
Journal: Molecular cancer
Published: August 30, 2019
SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals.
Journal: Cancer cell international
Published: December 05, 2018
COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.
Journal: Journal of thoracic disease
Published: May 01, 2018
UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis.
Journal: Cancer chemotherapy and pharmacology
Published: January 25, 2017
Last Updated: 09/26/2026